Schering Sues Another Generics Co. Over Clarinex
Schering Corp. has added generics maker Anchen Pharmaceuticals Inc. to the long list of companies it is targeting for patent infringement to protect its hold on the $722 million annual market...To view the full article, register now.
Already a subscriber? Click here to view full article